LABORATORY SCIENCES. 193-nm Excimer Laser Induced Fluorescence Detection of Fluoroquinolones in Rabbit Corneas
|
|
- Blake Bruce
- 5 years ago
- Views:
Transcription
1 LABORATORY SCIENCES 193- Excimer Laser Induced Fluorescence Detection of Fluoroquinolones in Rabbit Corneas Roy S. Chuck, MD, PhD; Ramez E. N. Shehada, PhD; Mehran Taban, MD; Tulaya Tungsiripat, MD; Paula M. Sweet, MT; Hebah N. Mansour, MD; Warren S. Grundfest, MD; Peter J. McDonnell, MD Objective: To measure the 193- excimer laser induced fluorescence of fluoroquinolone-treated cadaver rabbit corneas. Methods: Prior to ablation with a commercially available ophthalmic excimer laser (Nidek EC-5; Nidek Technologies, Pasadena, Calif), 35 cadaver rabbit corneas were treated with topical sterile balanced salt solution,.3% tobramycin sulfate, or the fluoroquinolones.3% ofloxacin,.5% levofloxacin,.3% ciprofloxacin hydrochloride, or.3% gatifloxacin. The fluorescence generated from each ablated corneal layer was measured and used to identify the presence of antibiotic. This was achieved by training a partial least-squares model to discriminate between the fluorescence spectra of antibiotic-treated and antibiotic-free (healthy) cornea. Antibiotic concentrations down to.6 µg/ml were detected with high accuracy. Assuming a constant ablation rate of.3 per laser pulse, the number of corneal layers ablated to reach antibiotic-free cornea is used to calculate the penetration depth of the antibiotic. Results: The mean ± SD penetration to a detectable depth was as follows:.3% ofloxacin, 7.1±3. ;.5% levofloxacin, 6.7±1.4 ;.3% ciprofloxacin, 1.2±.6 ; and.3% gatifloxacin, 7.±1.9. The penetration depth of.3% tobramycin could not be determined because its fluorescence spectrum overlapped with that of the native cornea. Conclusions: Topical administration of fluoroquinolonecontaining solutions results in measurable differences in laser-induced corneal fluorescence. Under these experimental conditions,.3% ofloxacin,.5% levofloxacin, and.3% gatifloxacin all appear to penetrate the epithelium significantly more than.3% ciprofloxacin (P.2). Clinical Relevance: Monitoring of laser-induced fluorescence may be helpful in determining the penetration depths and concentrations of topically applied fluoroquinolones within the cornea. Arch Ophthalmol. 24;122: Author Affiliations: Departments of Ophthalmology (Drs Chuck, Taban, Tungsiripat, and McDonnell and Ms Sweet) and Biomedical Engineering (Dr Chuck), University of California, Irvine; the Department of Biomedical Engineering and University of Southern California, Los Angeles (Dr Shehada); Medical Technology Laboratories, La Mirada, Calif (Dr Mansour); and Departments of Surgery, Electrical Engineering, and Bioengineering, University of California, Los Angeles (Dr Grundfest). Drs Chuck and McDonnell are now with the Wilmer Ophthalmological Institute, The Johns Hopkins University, Baltimore, Md. Financial Disclosure: None. WITH THE INCREASING popularity of such techniques as laser in situ keratomileusis (LASIK) and photorefractive keratectomy, excimer laser refractive surgery has emerged as one of the most common procedures performed in the United States. In 2 alone, more than 1.5 million of these procedures were performed in the United States, 1 and they are predicted to surpass surgical procedures for cataract as the most common eye operations conducted within the next several years. Over the years, numerous aspects of excimer laser technology have been scrutinized, including safety and the possible health adverse effects of laser application. One of the earliest concerns regarding the use of photorefractive keratectomy was initially raised by Loree et al 2 about the potential damage to surrounding ocular tissues. This group examined laser-induced fluorescence produced by the ablation of porcine corneas at 193- (argonfluoride), 248- (krypton-fluoride), and 38- (xenon-chloride) wavelengths using an intensified diode array detector system. They reported a potentially increased risk of secondary cataract formation from the low-energy UV light fluorescence produced during ablation of the cornea. Muller-Stolzenburg et al 3 also explored this issue in bovine corneas by placing a quartz fiber into the anterior chamber of the treated eye; they also expressed a similar concern. However, 2 subsequent and more complete analyses by Ediger 4 and Tuft et al 5 using photodiode systems independently showed a total UV energy dispersion that suggested a low risk of cataract from the laser-induced fluorescence. Unlike the slower photodiode systems, using an intensified charge-coupled detector system, we monitored real-time, 193- laser-induced fluorescence spec- (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
2 Off-Axis Parabolic Mirror Mirror Holder Laser Aperture Corneal Fluorescence Metal Holder XYZ Translator Figure 1. Experimental setup. Laser Beam Spectrograph Optical Table Computer XYZ Translator tra during transition from epithelium to stroma at clinically relevant laser fluences. We were able to corroborate these later studies by reporting qualitatively similar laserinduced fluorescence spectra. 6 In related work, using a pulsed 193- excimer laser at ablative energies on cadaver human and rabbit corneas, we determined the UV and visible fluorescence spectra as ablation progressed through the entirety of the cornea 7,8 with the ultimate goal of developing a fluorescence-guided spectrometer to provide an objective means to control excimer laser ablation. To our knowledge, however, a key question that has not been addressed to date is whether the topical application of fluorescent medications to the cornea might alter the outcomes of these studies. Use of such agents prior to excimer laser ablation might alter the pattern and intensity of fluorescence and related potential phototoxic reactions. Among the most common ophthalmic drops used preoperatively and postoperatively are fluoroquinolone antibiotic solutions. 9 In fact, over the past decade, fluoroquinolones have become the antibiotic class of choice for most topical ophthalmic antibiotic indications. The fluoroquinolones, derivatives of nalidixic acid, 1 are a fluorescent class of drug, and, thus, could potentially be detected by fluorescence spectroscopy. 11 Another issue in photorefractive surgery that has been examined throughout the past dozen years is the risk of postoperative infection. Although a rare phenomenon (.25%-1.2%), 12,13 infectious keratitis is a feared complication that is increasingly associated with unusual pathogens and pathogens resistant to the commonly used antiinfective agents. 9,14-2 The emergence of resistant strains of Staphylococcus aureus, the most common cause of infectious keratitis, to the familiar fluoroquinolones has not helped alleviate these concerns. Although many techniques have been used to assess the efficacy of antiinfective agents, drawbacks exist. In vitro tests fail to consider many factors such as drug penetrance into corneal tissue and the intrinsic anatomy of the eye. There have been numerous reports that have measured the antibiotic level in aqueous humor subsequent to aspiration Three groups have determined the intracorneal concentration of drug only after excision of corneal samples from patients undergoing penetrating keratoplasty Donnenfeld et al 28 enzymatically digested corneal samples. In articles by McDermott et al 29 and Diamond et al, 3 the specimen corneas were mechanically pulverized and analyzed spectroscopically after highperformance liquid chromatography for antibiotic concentration. To our knowledge, there have been no reported studies assessing the depth of penetration of fluoroquinolone antibiotics in corneal tissue as determined by real-time detection of excimer laser induced fluorescence during corneal ablation. This information is critical because it is the intracorneal level of antibiotic therapy that is thought to be the most important for optimal effectiveness against unforgiving pathogens involved in infectious keratitis. The purpose of this investigation was to measure the 193- excimer laser induced fluorescence spectrum of fluoroquinolone-treated cadaver rabbit cornea during excimer laser ablation. We sought to assess whether fluorescence detection of fluoroquinolone antibiotics in the cornea was possible on a shot-to-shot depth-dependent basis. METHODS EXCIMER LASER CORNEAL FLUORESCENCE ABLATIVE SPECTROSCOPY A schematic diagram of the experimental spectroscopy setup is shown in Figure 1. The main component is the ArF excimer laser corneal surgery system (model EC-5; Nidek Technologies Inc, Pasadena, Calif) operating at 193. The laser was operated in manual mode at 4 Hz, a spot size of mm, and an average energy output of 16.4 mj/pulse. The laser-induced fluorescence generated from the ablated corneal layers is reflected by a 2-in off-axis parabolic mirror (AlSiO-coated, model A ; Janos Technology Inc, Townsend, Vt) and focused in the entrance slit of the spectrograph (model SD2; Ocean Optics, Dunedin, Fla). The long-pass filter commonly used to eliminate the excitation radiation in laser-induced fluorescence spectroscopy was not needed because the mirror s coating did not reflect the 193- radiation scattered from the surface of the cornea. The spectrometer was set to automatically measure and save the fluorescence spectrum. Because of the extremely high absorption of the 193 in the corneal tissue, the fluorescence signal is known to arise from the ablated corneal layer. 4,5 Assuming a linear rate of removal of tissue with each laser pulse, a constant ablation rate of.3 /pulse was experimentally determined. EXPERIMENTAL PROTOCOL Fresh New Zealand white rabbit heads were obtained from a local slaughterhouse and kept at 4 C until the eyes were enucleated within 7 hours of death to maximize preservation of the corneal epithelium. The globes were stored in a moist chamber at 4 C for approximately 4 hours until time of use. A total of 35 globes were used in this study. An aminoglycoside (tobramycin sulfate) and 4 different fluoroquinolones (ofloxacin, levofloxacin, ciprofloxacin hydrochloride, and gatifloxacin) were tested, as these are some of the most common agents used for surgical prophylaxis. The applied solution concentrations were as follows:.3% tobramycin (Tobrex; Alcon Laboratories Inc, Fort Worth, Tex),.3% ofloxacin (Ocuflox; Allergan Inc, Irvine, Calif),.5% levofloxacin (Quixin; Santen USA Inc, Napa, Calif),.3% ciprofloxacin (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
3 (Ciloxan; Alcon Laboratories Inc), and.3% gatifloxacin (Zymar; Allergan Inc). Sterile balanced salt solution (BSS; Alcon Laboratories Inc) was used as a negative control. Four drops of BSS (n=5), tobramycin sulfate (n=5), ofloxacin (n=5), levofloxacin (n=3), ciprofloxacin hydrochloride (n=3), or gatifloxacin (n=4) were applied topically to separate corneas and allowed to rest for 1 minutes. Three drops of the appropriate solution were then administered a second time and globes were allowed to rest for an additional 5 minutes. To wash away excess antibiotic, especially at the corneal surface, each globe was rinsed with approximately 2 ml of lactated Ringer solution (Baxter Healthcare Corp, Deerfield, Ill) subsequent to antibiotic administration and prior to laser ablation. After washing, the globes were mounted on the laser platform and the corneas were ablated to perforation and the associated fluorescence spectra were measured. In a separate preparation, each of the above antibiotics was diluted to.6 µg/ml and topically applied to the corneas of another set of globes (n=2 for each antibiotic, 1 total) at room temperature and allowed to rest for 5 minutes. Three drops of the appropriate solution were then administered a second time and globes were allowed to rest for an additional 3 seconds. Accordingly, the anterior ( 1 ) of the antibiotic-treated cornea would have an antibiotic concentration equal to the known concentration of the topically applied antibiotic solution of.6 µg/ml. The globes were immediately mounted on the laser platform and the corneas were ablated for about 5 seconds; the resulting fluorescence spectra were measured. Assuming an ablation rate of.3 /pulse, the first 2 fluorescence spectra generated by the first 2 ablative pulses would be arising from the anterior.6- corneal layer and have the characteristic spectral features of corneal tissue saturated with.6 µg/ml of the specific antibiotic. PURE ANTIBIOTIC LASER-INDUCED FLUORESCENCE SPECTROSCOPY An aliquot (ie, 5 drops) of each antibiotic solution and the BSS was placed in an aluminum container at the focal point of the laser. The solution was irradiated with the excimer laser and the generated autofluorescence was measured. DETECTION OF ANTIBIOTIC PENETRATION The measured fluorescence spectra (25-65 ) were corrected for the dark current of the detector and the background light. Each spectrum was smoothed using a 5-point moving average window and resampled every 5 to reduce the number of spectral points from 379 to 76. DEVELOPMENT AND TRAINING OF THE MODEL For each antibiotic tested, a partial least-squares (PLS) model was developed for the discrimination between healthy and antibiotic-treated corneal tissue. The model is basically a numerical matrix that when multiplied by the fluorescence spectrum of an ablated corneal layer would yield a numerical value that is indicative of the antibiotic concentration in that layer. Detailed description of the PLS technique is available elsewhere The training inputs of the model were the first 2 fluorescence spectra acquired from the anterior 6 of healthy cornea (antibiotic free), and the first 2 fluorescence spectra acquired from the anterior.6 of the corneas treated with the diluted antibiotic (ie,.6 µg/ml). The training outputs of the model were 1 for the antibiotic-free cornea and 1 for antibiotic present with a concentration of.6 µg/ml and above. The PLS modeling algorithm is implemented using the scientific programming language MATLAB (version 5.3; The MathWorks Inc, Natick, Mass). The model s accuracy in detecting the antibiotics in the cornea was determined using the method of cross validation. In the latter, one input-output pair is excluded from the input-output data set used in training the model. The trained model is then used to predict the output (ie, antibiotic present/ absent) for the excluded input (ie, spectrum) and the result is compared with the actual output. This process is repeated for each input-output pair in the training data set and the model s prospective accuracy is calculated by: % Accuracy=NumberofCorrectlyPredictedOutput/ NumberofInput-OutputPairsintheDataSet Because the tested input-output pair was not used in training the model, this prospective accuracy is unbiased and represents the accuracy with which the model would detect the antibiotic s presence or absence in the cornea. A separate model is developed for each antibiotic to be tested for corneal penetration. DETERMINATION OF THE PENETRATION DEPTH Starting with the fluorescence spectrum produced by the ablation of the topmost corneal layer, the model processes each subsequent spectrum to estimate the presence or absence of antibiotic in the corresponding corneal layer. As described earlier, the model is trained to detect antibiotics with concentrations of.6 µg/ml or greater. The sequential number of the first spectrum indicating antibiotic-free cornea is multiplied by the assumed ablation rate (ie,.3 /pulse or spectrum) to calculate the maximum penetration depth of the antibiotic. RESULTS FLUORESCENCE SPECTRA OF PURE ANTIBIOTICS The fluorescence spectra of.3% ofloxacin,.5% levofloxacin,.3% gatifloxacin, and.3% ciprofloxacin are shown in Figure 2. Each antibiotic exhibited a characteristic fluorescence spectrum with peaks between 4 and 5. Levofloxacin produced the highest fluorescence intensity followed by ciprofloxacin, gatifloxacin, and ofloxacin, respectively. The spectral peak of ofloxacin, levofloxacin, and gatifloxacin occurred at 483, while ciprofloxacin exhibited double peaks at 433 and 483. The fluorescence spectrum of.3% tobramycin is shown in Figure 2E. In contrast to the other 4 antibiotics, tobramycin exhibited its peak fluorescence at about 3. The fluorescence spectrum of tobramycin coincided with the autofluorescence spectrum of the corneal structural proteins (ie, elastin and collagen), which prevented its spectroscopic detection in the corneal tissue. FLUORESCENCE SPECTRA OF ANTIBIOTIC-TREATED CORNEAS The fluorescence spectra of corneal ablation are plotted vs ablation depth in the 3-dimensional plots shown in Figure 3. The corneas treated with.3% tobramycin exhibited a single-peak fluorescence spectrum that is similar to that of healthy cornea. On the other hand, the corneas treated with.3% ofloxacin,.5% levofloxacin,.3% gatifloxacin, and.3% ciprofloxacin exhibited a charac- (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
4 A Ofloxacin B Levofloxacin C Gatifloxacin D Ciprofloxacin Hydrochloride E Tobramycin Sulfate Figure 2. The fluorescence spectra of 4 fluoroquinolones and tobramycin sulfate to test penetration depth in rabbit cornea. The following strengths were used:.3% ofloxacin (A),.5% levofloxacin (B),.3% gatifloxacin (C),.3% ciprofloxacin hydrochloride (D), and.3% tobramycin sulfate (E). Notice how the peak fluorescence of tobramycin is close to 3, in contrast with the rest of the fluoroquinolones tested. AU indicates absorbance units. teristic double-peak fluorescence spectrum. The first peak at about 3 coincides with the natural fluorescence of the structural proteins of the corneal tissue while the second peak at about 483 coincides with the characteristic fluorescence of the antibiotic. The fluorescence spectra of the diluted antibiotics in BSS are shown in Figure 4. The results indicate that even at this low concentration (.6 µg/ml), each antibiotic generates more than 4 times the fluorescence produced by BSS at the antibiotic s maximum emission wavelength. ANTIBIOTIC DETECTION IN THE CORNEA USING PLS MODELING The PLS model was able to detect the presence of antibiotics in concentrations of.6 µg/ml and above with a prospective accuracy of 9%. The maximum penetration depth of the antibiotic into the corneal tissue is given in the Table. The mean ± SD penetration to a detectable depth was as follows:.3% ofloxacin, 7.1±3. ;.5% levofloxacin, 6.7±1.4 ;.3% ciprofloxacin, 1.2±.6 ; and.3% gatifloxacin, 7.±1.9. The prospective accuracy of the above measurements is about 9% with a detection sensitivity of.6 µg/ml. Under these experimental conditions, none of the fluoroquinolone antibiotics tested appear to have diffused significantly past the intact epithelium. Ofloxacin, levofloxacin, and gatifloxacin all seem to penetrate the epithelium significantly more than ciprofloxacin (P.2). Tobramycin absorption could not be detected because of the model s inability to discriminate between its fluorescence spectrum and that of the cornea due to their close resemblance. COMMENT We have determined that applied fluoroquinolone antibiotic preoperatively prior to laser refractive surgery can certainly alter the excimer laser induced fluorescence patterns observed during surgery. Most of the doped fluorescence occurs between 4 to 5. It is not clear that observed intensities at these wavelengths in vitro translate into toxic irradiation in the clinical setting. Prospective human studies using clinical drug concentrations will need to be performed to answer this question. In this pilot study, we observed a detection sensitivity of better than.6 µg/ml. In future experiments, we will need to determine the lower limits of detection in titration studies. However, even in these preliminary studies, the lowest concentration of fluoroquinolone antibiotics tested,.6 µg/ml, is well below the minimum inhibitory concentrations of many ocular bacterial isolates. 34 Anticipated improvements in our fluorescence collection and detection systems should result in even better detection limits than our current arrangement. Thus, we (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
5 A Healthy Cornea B.3% Tobramycin Sulfate C.3% Ofloxacin Ablation Depth, Ablation Depth, Ablation Depth, D.5% Levofloxacin E.3% Gatifloxacin F.3% Ciprofloxacin Hydrochloride Ablation Depth, Ablation Depth, Ablation Depth, Figure 3. The 3-dimensional representation of mean fluorescence spectra vs the ablation depth in rabbit corneas treated with 4 fluoroquinolones and.3% tobramycin sulfate. The treatments were applied as follows: A, balanced salt solution (n=5); B,.3% tobramycin (n=5); C,.3% ofloxacin (n=5); D,.5% levofloxacin (n=3); E,.3% gatifloxacin (n=4); and F,.3% ciprofloxacin hydrochloride (n=3). AU indicates absorbance units. should be able to detect these antibiotics in the cornea at the level of their minimum inhibitory concentrations for many more bacterial species. Moreover, different than most current techniques used to determine the total corneal antibiotic depot, we should be able to determine these values in a depth-dependent manner in vivo. Knowledge of the antibiotic concentration gradients will be invaluable during lamellar corneal surgery, for example, LASIK and treatment of corneal infections at specific depths. If fluoroquinolones do not penetrate much past the epithelium immediately after application to intact epithelium, the epithelial levels of fluoroquinolone would increase the fluorescence during transepithelial ablation. This should not be a concern with LASIK. Under our in vitro experimental conditions, the current topical fluoroquinolone antibiotics did not penetrate very deeply past the corneal surface. Thus, repeated and frequent application might be needed to accumulate enough of the drug in the deeper layers of the cornea to reach therapeutic concentrations. Live animal and human trials are needed to determine antibiotic penetration in vivo under normal conditions with intact epithelium, Bowman layer, and anterior stroma. Possible explanations for greater penetration of antibiotics detected in living corneas include the repeated administration in many in vivo studies and coapplication of epithelium-damaging drugs such as topical anesthetics, as well as the intraoperative dehydration that occurs when the eyelids are opened with an eyelid speculum under the operating microscope. The resulting dehydration will cause the cornea to imbibe an antibioticcontaining solution. Because we did not first desiccate our corneas under the operating microscope, our experimental situation did not completely mimic the clinical enviroent. There are 2 major factors that enhance the statistical reliability (significance) of our small data set in this pilot study. First, the measured penetration depths for each drug seemed to be significantly close with narrow standard deviations. Second, the number of corneal samples does not affect the accuracy of the penetration-depth measurement because this measurement is determined from the hundreds of fluorescence spectra acquired during the corneal ablation process. The cross-validated accuracy of the penetration-depth measurements exceeded 9%. Initially, 3 globes were tested for each antibiotic. Based on gross visual inspection of the initial unprocessed data, a few extra globes were added to validate that the fluoroquinolones did not penetrate past the epithelium (Table). The final spectral analysis of the large data sets for each globe proved that all of the measured spectra were valid. If we truly only achieve therapeutic levels of fluoroquinolone antibiotic in the epithelium after topical drug administration shortly before surgery, then we may need to reconsider our standards of preoperative- and postoperative-dosing regimens. Methods to increase the corneal drug depot include increasing applied topical drug concentrations and frequency of dosing, and application only after creation of a surgical wound when an in- (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
6 A.3% Ofloxacin B.5% Levofloxacin C.3% Gatifloxacin D.3% Ciprofloxacin Hydrochloride E BSS Figure 4. Fluorescence spectra of.3% ofloxacin (A),.5% levofloxacin (B),.3% gatifloxacin (C), and.3% ciprofloxacin hydrochloride (D) diluted with balanced salt solution (BSS), each with final concentrations of.6 µg/ml; E, Fluorescence spectra of BSS alone. AU indicates absorbance units. Table. Penetration Depth of Each Antibiotic Into Rabbit Corneal Tissue Antibiotic Penetration Depth, Case No..3% Ofloxacin.3% Gatifloxacin.5% Levofloxacin.3% Ciprofloxacin Hydrochloride NA NA NA NA NA Mean ± SD 7.1 ± ± ± ±.6 Prospective accuracy, %* Abbreviation: NA, not applicable. *Projected values are for antibiotic concentrations of.6 µg/ml or greater. tact epithelial barrier is no longer present. Among the antibiotics tested, only.5% levofloxacin was not used near its maximum solubility concentration. Finally, with respect to photorefractive keratectomy, if the therapeutic antibiotic depot does reside for the most part in the epithelium, then preoperative antibiotic administration provides little advantage, as the epithelium is ablated away during the initial stages of surgery. During this ablation of doped epithelium, one must also be wary of the generated secondary fluorescence derived from the fluoroquinolone dopant. In LASIK, however, the epithelium, and, thus, possibly the drug depot, remains intact for the most part. Because infections after anterior segment surgery are typically caused by the patient s own resident flora that may be recovered from the conjunctivae, eyelids, and nasopharynx, it would still be helpful in any case to apply these drops preoperatively, as they may be effective at reducing conjunctival flora. Submitted for Publication: June 5, 23; final revision received March 9, 24; accepted April 29, 24. Correspondence: Roy S. Chuck, MD, PhD, Wilmer Ophthalmological Institute, John Hopkins University, Jefferson Building, 6 N Wolfe St, Baltimore, MD 2/ (rchuck1@jhmi.edu). (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
7 Funding/Support: This study was supported by grants from Nidek Technologies Inc, Pasadena, Calif (Drs Chuck and Shehada) and grant EY412-1A1 from the National Eye Institute, National Institutes of Health, Bethesda, Md (Dr Chuck). REFERENCES 1. McDonnell PJ. Emergence of refractive surgery. Arch Ophthalmol. 2;118: Loree TR, Johnston TM, Birmingham BS, McCord RC. Fluorescence spectra of corneal tissue under excimer laser irradiation. Proc SPIE. 1988;98:6. 3. Muller-Stolzenburg NW, Muller G, Buchwald HJ, Schrunder S. UV exposure of the lens during 193- excimer laser corneal surgery. Arch Ophthalmol. 199; 18: Ediger MN. Excimer-laser-induced fluorescence of rabbit cornea: radiometric measurement through the cornea. Lasers Surg Med. 1991;11: Tuft S, Al-Dhahir R, Dyer P, Zhu Z. Characterization of the fluorescence spectra produced by excimer laser irradiation of the cornea. Invest Ophthalmol Vis Sci. 199;31: Phillips AF, McDonnell PJ. Laser-induced fluorescence during photorefractive keratectomy: a method for controlling epithelial removal. Am J Ophthalmol. 1997; 123: Chuck RS, Arnoldussen ME, Cohen D, et al. 193 excimer laser-induced fluorescence from cadaveric rabbit corneas. Revista Oftalmoigical Venezuela. 21; 57: Cohen D, Chuck RS, Bearman G, McDonnell PJ, Grundfest WS. Ablation spectra of the human cornea. J Biomed Opt. 21;6: Goldstein MH, Kowalski RP, Gordon YJ. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology. 1999;16: Neu HC. Chemical evolution of the fluoroquinolone antimicrobial agents. Am J Med. 1989;87(suppl 6C):2S-9S. 11. Liang H, Kays MB, Sowinski KM. Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma. J Chromatogr B Analyt Technol Biomed Life Sci. 22;772: Jain S, Azar DT. Eye infections after refractive keratotomy. J Refract Surg. 1996; 12: Al-Rajhi AA, Wagoner MD, Badr IA, al-saif A, Mahmood M. Bacterial keratitis following phototherapeutic keratectomy. J Refract Surg. 1996;12: Forster W, Becker K, Hungermann D, Busse H. Methicillin-resistant Staphylococcus aureus keratitis after excimer laser photorefractive keratectomy. J Cataract Refract Surg. 22;28: Kaldawy RM, Sutphin JE, Wagoner MD. Acanthamoeba keratitis after photorefractive keratectomy. J Cataract Refract Surg. 22;28: Heidemann DG, Clune M, Dunn SP, Chow CY. Infectious keratitis after photorefractive keratectomy in a comanaged setting. J Cataract Refract Surg. 2; 26: Dunphy D, Andrews D, Seamone C, Ramsey M. Fungal keratitis following excimer laser photorefractive keratectomy. Can J Ophthalmol. 1999;34: Brancato R, Carones F, Venturi E, Cavallero A, Gesu G. Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. Arch Ophthalmol. 1997; 115: Wee WR, Kim JY, Choi YS, Lee JH. Bacterial keratitis after photorefractive keratectomy in a young, healthy man. J Cataract Refract Surg. 1997;23: Amayem A, Ali AT, Waring GO III, Ibrahim O. Bacterial keratitis after photorefractive keratectomy. J Refract Surg. 1996;12: Kalayci D, Basci N, Akpek E, Hasiripi H, Bozkurt A. Penetration of topical.3% ciprofloxacin into human aqueous humor. Ophthalmic Surg Lasers. 1996;27: Hanioglu-Kargi S, Basci N, Soysal H, et al. The penetration of ofloxacin into human aqueous humor given by various routes. Eur J Ophthalmol. 1998;8: Basci NE, Bozkurt A, Kalayci D, Kayaalp SO. Rapid liquid chromatographic assay of ciprofloxacin in human aqueous humor. J Pharm Biomed Anal. 1996; 14: Basci NE, Hanioglu-Kargi S, Soysal H, Bozkurt A, Kayaalp SO. Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detection. J Pharm Biomed Anal. 1997;15: Cekic O, Batman C, Totan Y, et al. Penetration of ofloxacin and ciprofloxacin in aqueous humor after topical administration. Ophthalmic Surg Lasers. 1999; 3: Beck R, van Keyserlingk J, Fischer U, Guthoff R, Drewelow B. Penetration of ciprofloxacin, norfloxacin, and ofloxacin into the aqueous humor using different topical application modes. Graefes Arch Clin Exp Ophthalmol. 1999;237: Cantor LB, Donnenfeld E, Katz LJ, et al. Penetration of ofloxacin and ciprofloxacin into the aqueous humor of eyes with functioning filtering blebs. Arch Ophthalmol. 21;119: Donnenfeld ED, Perry HD, Snyder RW, et al. Intracorneal, aqueous humor, and vitreous humor penetration of topical and oral ofloxacin. Arch Ophthalmol. 1997; 115: McDermott ML, Tran TD, Cowden JW, Bugge CJL. Corneal stromal penetration of topical ciprofloxacin in humans. Ophthalmology. 1993;1: Diamond JP, White L, Leeming JP, Bing Hoh H, Easty DL. Topical.3% ciprofloxacin, norfloxacin, and ofloxacin in treatment of bacterial keratitis: a new method for comparative evaluation of ocular drug penetration. Br J Ophthalmol. 1995; 79: Kowalski BR, ed. Chemometrics, Mathematics and Statistics in Chemistry. Hingham, Mass: D Kluwer Academic Publishers; Geladi P, Kowalski BR. Partial least-squares regression: a tutorial. Anal Chim Acta. 1986;185: Wold H. Research Papers in Statistic. In: David FN, ed. New York, NY: John Wiley & Sons Inc; 1966: Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth-generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol. 22;133: (REPRINTED) ARCH OPHTHALMOL / VOL 122, NOV Downloaded From: on 11/4/ American Medical Association. All rights reserved.
Role of Moxifloxacin in Bacterial Keratitis
Original Article Role of Moxifloxacin in Bacterial Keratitis Aamna Jabran, Aurengzeb Sheikh, Syed Ali Haider, Zia-ud-din Shaikh Pak J Ophthalmol 29, Vol. 25 No. 2.................................................................................
More informationPathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California,
Pathogens and Antibiotic Sensitivities in Post- Phacoemulsification Endophthalmitis, Kaiser Permanente, California, 2007-2012 Geraldine R. Slean, MD, MS 1 ; Neal H. Shorstein, MD 2 ; Liyan Liu, MD, MS
More informationTopical Antibiotic Update. Brad Sutton, O.D., F.A.A.O. Indiana University School of Optometry Indianapolis Eye Care Center No financial disclosures
Topical Antibiotic Update Brad Sutton, O.D., F.A.A.O. Indiana University School of Optometry Indianapolis Eye Care Center No financial disclosures What do we have? We currently have many highly effective
More informationClinical Study Update: Surgical Therapeutics
The Newsmagazine of the American Society of Cataract & Refractive Surgery EYEWORLD SUPPLEMENT February 2007 Clinical Study Update: Surgical Therapeutics This item contains a non-fda approved use. Please
More informationFinancial disclosures
Financial disclosures Named co-inventor on PCT applications CH2012/0000090 and PCT2014/CH000075 Chief Scientific Officer EMAGine SA Historical decision in 2004 1. Future: extremely thin corneas Dresden
More informationCataracts are the leading cause of visual impairment and
CLINICAL SCIENCE Safety of Ophthalmic Suspension 0.6% in Cataract and LASIK Surgery Patients Parag A. Majmudar, MD,* and Thomas E. Clinch, MD Purpose: The aim of the study was to evaluate the safety of
More informationOphthalmologists are beginning to turn to
EyeWorld Supplement July 2005 Maximizing Outcomes with Effective Therapeutics Live from ASCRS, Washington, DC A special report from EyeWorld s 2005 Educational Symposium Richard L. Lindstrom, M.D., is
More informationClinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia
Clinical Features, Antibiotic Susceptibility Profile, and Outcomes of Infectious Keratitis Caused by Stenotrophomonas maltophilia Sotiria Palioura, MD, MSc, PhD Cornea & External Disease Specialist Athens
More informationBACTERIAL ENDOPHTHALMITIS
CLINICAL SCIENCES Vitreous and Aqueous Penetration of rally Administered Moxifloxacin in umans Seenu M. ariprasad, MD; Gaurav K. Shah, MD; William F. Mieler, MD; Leonard Feiner, MD; Kevin J. Blinder, MD;
More informationREVIEW OF OPHTHALMOLOGY SECTION OF WHO MODEL LIST OF ESSENTIAL MEDICINES. Sight Savers International and The Vision 2020 Technology Group
REVIEW OF OPHTHALMOLOGY SECTION OF WHO MODEL LIST OF ESSENTIAL MEDICINES Anti infective agent Medicine suggested for inclusion Ciprofloxacin: 0.3 % eye drops Application submitted by Sight Savers International
More informationPACK-CXL. for infectious keratitis. Farhad Hafezi, MD PhD. Professor of Ophthalmology Keck School of Medicine USC Los Angeles, USA
PACK-CXL for infectious keratitis Farhad Hafezi, MD PhD Professor of Ophthalmology University of Geneva Geneva, Switzerland Medical Director ELZA Institute Zurich, Switzerland Research Group Leader Lab.
More informationThe Battle of Resistance: Treating Infections in the Age of Resistance
The Age of Modern Medicine The Battle of Resistance: Treating Infections in the Age of Resistance Mark T. Dunbar, O.D., F.A.A.O. Bascom Palmer Eye Institute University of Miami, Miller School of Med Miami,
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Adnexal pain, in farm animals, ocular squamous cell carcinoma and, 431 432 Age, as factor in OSCC, 518 Akinesia, in eye examination in
More informationProspective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora
European Journal of Ophthalmology / Vol. 17 no. 5, 2007 / pp. 689-695 Prospective randomized comparison of 1-day versus 3-day application of topical levofloxacin in eliminating conjunctival flora C.N.
More informationWhat are the Best Topical Agents for Prophylaxis?
What are the Best Topical Agents for Prophylaxis? The top antibiotics are those that are most effective against the majority of bacteria, rapidly kill the offending organisms, penetrate the eye well, and
More informationStudy of Bacteriological Profile of Corneal Ulcers in Patients Attending VIMS, Ballari, India
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 5 Number 7 (2016) pp. 200-205 Journal homepage: http://www.ijcmas.com Original Research Article http://dx.doi.org/10.20546/ijcmas.2016.507.020
More informationProphylactic antibiotic timing and dosage. Dr. Sanjeev Singh AIMS, Kochi
Prophylactic antibiotic timing and dosage Dr. Sanjeev Singh AIMS, Kochi Meaning - Webster Medical Definition of prophylaxis plural pro phy lax es \-ˈlak-ˌsēz\play : measures designed to preserve health
More informationAmerican Association of Feline Practitioners American Animal Hospital Association
American Association of Feline Practitioners American Animal Hospital Association Basic Guidelines of Judicious Therapeutic Use of Antimicrobials August 1, 2006 Introduction The Basic Guidelines to Judicious
More informationINFECTION PROPHYLAXIS
Risk MAN A CME MONOGRAPH GEMENT Update in INFECTION PROPHYLAXIS for Ocular Surgery Highlights from a Roundtable Discussion ORIGINAL RELEASE: SEPTEMBER 1, 2010 LAST REVIEW: AUGUST 17, 2010 EXPIRATION: SEPTEMBER
More informationCiprofloxacin Versus Tobramycin for the Treatment of Staphylococcal Keratitis
Ciprofloxacin Versus Tobramycin for the Treatment of Staphylococcal Keratitis Michelle C. Callegan* Lee S. Engel,* James M. Hill,*"f and Richard J. O'Callaghan* Purpose. To compare the chemotherapeutic
More information6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS
6.0 ANTIBACTERIAL ACTIVITY OF CAROTENOID FROM HALOMONAS SPECIES AGAINST CHOSEN HUMAN BACTERIAL PATHOGENS 6.1 INTRODUCTION Microorganisms that cause infectious disease are called pathogenic microbes. Although
More informationOptoacoustic imaging of an animal model of prostate cancer
Optoacoustic imaging of an animal model of prostate cancer Michelle P. Patterson 1,2, Michel G. Arsenault 1, Chris Riley 3, Michael Kolios 4 and William M. Whelan 1,2 1 Department of Physics, University
More informationVisit ABLE on the Web at:
This article reprinted from: Lessem, P. B. 2008. The antibiotic resistance phenomenon: Use of minimal inhibitory concentration (MIC) determination for inquiry based experimentation. Pages 357-362, in Tested
More informationBacterial Resistance. The Battle of the Bugs: Treating Infections in the Age of Resistance. How Resistance Develops. The Age of Modern Medicine
The Age of Modern Medicine The Battle of the Bugs: Treating Infections in the Age of Resistance Mark T. Dunbar, O.D., F.A.A.O. Bascom Palmer Eye Institute University of Miami, Miller School of Med Miami,
More informationEuropean Public MRL assessment report (EPMAR)
18 March 2016 EMA/CVMP/619817/2015 Committee for Medicinal Products for Veterinary Use European Public MRL assessment report (EPMAR) Gentamicin (all mammalian food producing species and fin fish) On 3
More informationCADTH. Rapid Response Report: Peer-Reviewed Summary with Critical Appraisal. Canadian Agency for Drugs and Technologies in Health
Canadian Agency for Drugs and Technologies in Health Agence canadienne des médicaments et des technologies de la santé Rapid Response Report: Peer-Reviewed Summary with Critical Appraisal CADTH Intracameral
More informationAuthor - Dr. Josie Traub-Dargatz
Author - Dr. Josie Traub-Dargatz Dr. Josie Traub-Dargatz is a professor of equine medicine at Colorado State University (CSU) College of Veterinary Medicine and Biomedical Sciences. She began her veterinary
More informationVeterinary Ophthalmology
Veterinary Ophthalmology Eyelids Protect the eye Provides part of and spreads the tear film Regulates the amount of light that enters the eye Clears foreign material Third Eyelid Protects the cornea by
More informationDelayed-Onset Post-Keratoplasty Endophthalmitis Caused by Vancomycin-Resistant Enterococcus faecium
This is an Open Access article licensed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License (www.karger.com/oa-license), applicable to the online version of the article
More informationPrinciples of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1
Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination
More informationCOMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE
European Medicines Agency Veterinary Medicines and Inspections EMEA/CVMP/211249/2005-FINAL July 2005 COMMITTEE FOR MEDICINAL PRODUCTS FOR VETERINARY USE DIHYDROSTREPTOMYCIN (Extrapolation to all ruminants)
More informationBacterial keratitis is a major cause of corneal opacity and loss
Immunology and Microbiology An In Vitro Investigation of Synergy or Antagonism between Antimicrobial Combinations against Isolates from Bacterial Keratitis Henri Sueke, 1,2 Stephen B. Kaye, 1 Timothy Neal,
More informationEvaluation of Moxifloxacin 0.5% Eye Drops in Treatment of Bacterial Corneal Ulcers
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 11 Ver. II (Nov. 2017), PP 15-19 www.iosrjournals.org Evaluation of Moxifloxacin 0.5% Eye Drops
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationLABORATORY SCIENCES. Treatment of Experimental Bacterial Keratitis With Topical Trovafloxacin
LABORATORY SCIENCES Treatment of Experimental Bacterial Keratitis With Topical Trovafloxacin Irina S. Barequet, MD; Paul Denton, BS; Gerard J. Osterhout, MS; Suhas Tuli, MD; Terrence P. O Brien, MD Objective:
More informationFerriNaphth: A Fluorescent Dosimeter for Redox Active Metals
Supporting Information FerriNaphth: A Fluorescent Dosimeter for Redox Active Metals Randy K. Jackson, Yu Shi, Xudong Yao and Shawn Burdette * Department of Chemistry, University of Connecticut, 55 North
More informationTwo Cases of Corneal Ulcer due to Methicillin-Resistant Staphylococcus aureus in High Risk Groups
pissn: 1011-8942 eissn: 2092-9382 Korean J Ophthalmol 2010;24(4):240-244 DOI: 10.3341/kjo.2010.24.4.240 Two Cases of Corneal Ulcer due to Methicillin-Resistant Staphylococcus aureus in High Risk Groups
More informationPierre-Louis Toutain, Ecole Nationale Vétérinaire National veterinary School of Toulouse, France Wuhan 12/10/2015
Antimicrobial susceptibility testing for amoxicillin in pigs: the setting of the PK/PD cutoff value using population kinetic and Monte Carlo Simulation Pierre-Louis Toutain, Ecole Nationale Vétérinaire
More informationAnalytical Chemistry Insights 2014:9
pen Access: Full open access to this and thousands of other papers at http://www.la-press.com. Analytical Chemistry Insights A UPLC MS Method for the Determination of floxacin Concentrations in Aqueous
More informationSZENT ISTVÁN UNIVERSITY. Doctoral School of Veterinary Science
SZENT ISTVÁN UNIVERSITY Doctoral School of Veterinary Science Comparative pharmacokinetics of the amoxicillinclavulanic acid combination in broiler chickens and turkeys, susceptibility and stability tests
More informationAntibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice?
Antibiotics in vitro : Which properties do we need to consider for optimizing our therapeutic choice? With the support of Wallonie-Bruxelles-International 1-1 In vitro evaluation of antibiotics : the antibiogram
More informationDevelopment and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker
Development and validation of a HPLC analytical assay method for amlodipine besylate tablets: A Potent Ca +2 channel blocker Richa Sah* and Saahil Arora 1. ISF College of Pharmacy, Moga, Punjab, India
More informationVITREOUS PENETRATION OF ORALLY ADMINISTERED GATIFLOXACIN IN HUMANS
VITREOUS PENETRATION OF ORALLY ADMINISTERED GATIFLOXACIN IN HUMANS BY Seenu M. Hariprasad, MD (BY INVITATION), William F. Mieler, MD, AND Eric R. Holz, MD (BY INVITATION) ABSTRACT Purpose: To investigate
More informationSIMPLE U.V. SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF OFLOXACIN IN PHARMACEUTICAL FORMULATIONS
Int. J. Chem. Sci.: 8(2), 2010, 983-990 SIMPLE U.V. SPECTROPHOTOMETRIC METHODS FOR THE ESTIMATION OF OFLOXACIN IN PHARMACEUTICAL FORMULATIONS C. SOWMYA *, Y. PADMANABHA REDDY, J. RAVINDRA REDDY, M. SIVA
More informationBarriers to Intravenous Penicillin Use for Treatment of Nonmeningitis
JCM Accepts, published online ahead of print on 7 July 2010 J. Clin. Microbiol. doi:10.1128/jcm.01012-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationEar drops suspension. A smooth, uniform, white to off-white viscous suspension.
SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT OTOMAX EAR DROPS SUSPENSION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml of the veterinary medicinal product contains:
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationUPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM
UPDATE ON ANTIMICROBIAL STEWARDSHIP REGULATIONS AND IMPLEMENTATION OF AN AMS PROGRAM Diane Rhee, Pharm.D. Associate Professor of Pharmacy Practice Roseman University of Health Sciences Chair, Valley Health
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Information Technology EMEA/MRL/728/00-FINAL April 2000 COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS STREPTOMYCIN AND
More informationAntimicrobial utilization: Capital Health Region, Alberta
ANTIMICROBIAL STEWARDSHIP Antimicrobial utilization: Capital Health Region, Alberta Regionalization of health care services in Alberta began in 1994. In the Capital Health region, restructuring of seven
More informationAppropriate antimicrobial therapy in HAP: What does this mean?
Appropriate antimicrobial therapy in HAP: What does this mean? Jaehee Lee, M.D. Kyungpook National University Hospital, Korea KNUH since 1907 Presentation outline Empiric antimicrobial choice: right spectrum,
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationCOMMITTEE FOR VETERINARY MEDICINAL PRODUCTS
The European Agency for the Evaluation of Medicinal Products Veterinary Medicines and Inspections EMEA/CVMP/627/01-FINAL COMMITTEE FOR VETERINARY MEDICINAL PRODUCTS GUIDELINE FOR THE DEMONSTRATION OF EFFICACY
More information4/29/12. Dr. Taravella does not have any financial interest in the material, methods or techniques presented.
Dr. Taravella does not have any financial interest in the material, methods or techniques presented. Michael J. Taravella Professor of Ophthalmology Rocky Mountain Lions Eye Institute University of Colorado
More informationChallenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S.
Challenges and opportunities for rapidly advancing reporting and improving inpatient antibiotic use in the U.S. Overview of benchmarking Antibiotic Use Scott Fridkin, MD, Senior Advisor for Antimicrobial
More informationIn vitro antibiotic resistance in bacterial keratitis in London
Br J Ophthalmol 2000;84:687 691 687 Moorfields Eye Hospital, London EC1V 2PD SJTuft Institute of Ophthalmology, London EC1V 9QS M Matheson Correspondence to: Mr S J Tuft, Moorfields Eye Hospital, City
More informationImproved Photoacoustic Generator
Int J Thermophys (2014) 35:2302 2307 DOI 10.1007/s10765-014-1751-9 Improved Photoacoustic Generator T. Borowski A. Burd M. Suchenek T. Starecki Received: 17 November 2013 / Accepted: 23 September 2014
More informationInternational Journal of Science, Environment and Technology, Vol. 6, No 1, 2017,
International Journal of Science, Environment and Technology, Vol. 6, No 1, 2017, 872 876 ISSN 2278-3687 (O) 2277-663X (P) Case report SURGICAL MANAGEMENT OF BILATERAL HYPERMATURE CATARACT BY EXTRACAPSULAR
More informationAntimicrobial Stewardship Strategy:
Antimicrobial Stewardship Strategy: Prospective audit with intervention and feedback Formal assessment of antimicrobial therapy by trained individuals, who make recommendations to the prescribing service
More informationOptimal Duration for the Use of 0.5% Levofloxacin Eye Drops Before Vitreoretinal Surgery
original clinical study Optimal Duration for the Use of.5% Levofloxacin Eye Drops Before Vitreoretinal Surgery Xiaoxin Li, MD,* Xiaoling Liang, MD, Luosheng Tang, MD, Junjun Zhang, MD, Lijun Shen, MD,
More informationDebate Series editors: Susan Lightman and Peter McCluskey
1167... Series editors: Susan Lightman and Peter McCluskey Correspondence to: M Daniell, Royal Victorian Eye and Ear Hospital, Melbourne, Victoria, 3065, Australia; daniellm@ozemail.com.au Accepted for
More informationPreventing Postoperative Infection and Inflammation
Chapter 15 Preventing Postoperative Infection and Inflammation Nick Mamalis, MD Preventing Postoperative Infection Postoperative endophthalmitis is a rare but potentially devastating complication of cataract
More informationGive the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS
Give the Right Antibiotics in Trauma Mitchell J Daley, PharmD, BCPS Clinical Pharmacy Specialist, Critical Care Dell Seton Medical Center at the University of Texas and Seton Healthcare Family Clinical
More informationDREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS
DREXEL UNIVERSITY COLLEGE OF MEDICINE ANIMAL CARE AND USE COMMITTEE POLICY FOR PREOPERATIVE AND POSTOPERATIVE CARE FOR NON-RODENT MAMMALS OBJECTIVE: This policy is to ensure that appropriate provisions
More informationReview Article New Treatments for Bacterial Keratitis
Hindawi Publishing Corporation Journal of Ophthalmology Volume 2012, Article ID 831502, 7 pages doi:10.1155/2012/831502 Review Article New Treatments for Bacterial Keratitis RaymondL.M.Wong, 1 R. A. Gangwani,
More informationمادة االدوية المرحلة الثالثة م. غدير حاتم محمد
م. مادة االدوية المرحلة الثالثة م. غدير حاتم محمد 2017-2016 ANTIMICROBIAL DRUGS Antimicrobial drugs Lecture 1 Antimicrobial Drugs Chemotherapy: The use of drugs to treat a disease. Antimicrobial drugs:
More informationWound Management. Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical Officer, Applied Tissue Technologies LLC
Wound Management The use of a Platform Wound Device for Topical Treatment of Infections and for Delivery of Negative Pressure Elof Eriksson MD PhD Professor Emeritus, Harvard Medical School Chief Medical
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationCHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY
CHAPTER:1 THE RATIONAL USE OF ANTIBIOTICS BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Antibiotics One of the most commonly used group of drugs In USA 23
More informationPublic Assessment Report Paediatric data. EXOCIN (OCUFLOX) Ofloxacin. Marketing Autorisation Holder: Allergan
Public Assessment Report Paediatric data EXOCIN (OCUFLOX) Ofloxacin Marketing Autorisation Holder: Allergan Rapporteur: Co-Rapporteur: Currently approved indication(s): Pharmaceutical form(s) and strengths
More informationUSA Product Label CLINTABS TABLETS. Virbac. brand of clindamycin hydrochloride tablets. ANADA # , Approved by FDA DESCRIPTION
VIRBAC CORPORATION USA Product Label http://www.vetdepot.com P.O. BOX 162059, FORT WORTH, TX, 76161 Telephone: 817-831-5030 Order Desk: 800-338-3659 Fax: 817-831-8327 Website: www.virbacvet.com CLINTABS
More informationAdoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study.
Adoption of intracameral antibiotic prophylaxis of endophthalmitis following cataract surgery: update on the ESCRS Endophthalmitis Study. Item Type Article Authors Barry, Peter Citation Barry P. Adoption
More informationMAGNITUDE OF ANTIMICROBIAL USE. Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges
Antimicrobial Stewardship in Acute and Long Term Healthcare Facilities: Design, Implementation and Challenges John A. Jernigan, MD, MS Division of Healthcare Quality Promotion Centers for Disease Control
More informationA Unique Approach to Managing the Problem of Antibiotic Resistance
A Unique Approach to Managing the Problem of Antibiotic Resistance By: Heather Storteboom and Sung-Chul Kim Department of Civil and Environmental Engineering Colorado State University A Quick Review The
More informationSHC Surgical Antimicrobial Prophylaxis Guidelines
SHC Surgical Antimicrobial Prophylaxis Guidelines I. Purpose/Background This document is based upon the 2013 consensus guidelines from American Society of Health-System Pharmacists (ASHP), the Infectious
More informationDynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
2011 International Conference on Biomedical Engineering and Technology IPCBEE vol.11 (2011) (2011) IACSIT Press, Singapore Dynamic Drug Combination Response on Pathogenic Mutations of Staphylococcus aureus
More informationAntimicrobial Stewardship and Use Monitoring Michael D. Apley, DVM, PhD, DACVCP Kansas State University, Manhattan, KS
Antimicrobial Stewardship and Use Monitoring Michael D. Apley, DVM, PhD, DACVCP Kansas State University, Manhattan, KS Defining antimicrobial stewardship is pivotal to our ability as veterinarians to continue
More informationAll India Ophthalmological Society members survey results: Cataract surgery antibiotic prophylaxis current practice pattern 2017
Original Article All India Ophthalmological Society members survey results: Cataract antibiotic prophylaxis current practice pattern 2017 Prafulla Kumar Maharana, Jay K Chhablani 1, Tara Prasad Das 1,
More informationUSA Product Label LINCOCIN. brand of lincomycin hydrochloride tablets. brand of lincomycin hydrochloride injection, USP. For Use in Animals Only
USA Product Label http://www.vetdepot.com PHARMACIA & UPJOHN COMPANY Division of Pfizer Inc. Distributed by PFIZER INC. 235 E. 42ND ST., NEW YORK, NY, 10017 Telephone: 269-833-4000 Fax: 616-833-4077 Customer
More informationPOST-OPERATIVE ANALGESIA AND FORMULARIES
POST-OPERATIVE ANALGESIA AND FORMULARIES An integral component of any animal protocol is the prevention or alleviation of pain or distress, such as that associated with surgical and other procedures. Pain
More informationDisclosure. Update on management of fungal keratitis. Acknowledgments. World Blindness 1993
Update on management of fungal keratitis Tom Lietman, MD F I Proctor Foundation Department of Ophthalmology University of California San Francisco Disclosure Voriconazole donated by Pfizer Natamycin and
More informationSPECTROPHOTOMETRIC ESTIMATION OF MELOXICAM IN BULK AND ITS PHARMACEUTICAL FORMULATIONS
SPECTROPHOTOMETRIC ESTIMATION OF MELOXICAM IN BULK AND ITS PHARMACEUTICAL FORMULATIONS B.DHANDAPANI, S.ESWARA MURALI, N. SUSRUTHA, RAMA SWETHA, S K. SONIA RANI, T. SARATH BABU, G.V. SEETHARAMANJANEYULU,
More informationRoundtable Notes from 2013 IEOC/Acrivet Symposium
Roundtable Notes from 2013 IEOC/Acrivet Symposium Cornea Various discussions on linear keratopathy, IMMK, and other cornea topics Keypoint: 1. We hypothesize that linear keratopathy (Haab s striae) is
More informationNebcin0 in the treatment of experimental
Brit. J. Ophthal. (15) 5, 5 Nebcin in the treatment of experimental Pseudomonas keratitis RUBENS BELFORT, JR., GLBERT SMOLN, MASAO OKUMOTO, and HONG BOK KM From the Francis. Proctor Foundation for Research
More informationThe Infected Implant in Orthopaedic Reconstruction: An Update on the Clinical and Molecular Approaches to Prevention and Diagnosis
The Infected Implant in Orthopaedic Reconstruction: An Update on the Clinical and Molecular Approaches to Prevention and Diagnosis (Organized by the Musculoskeletal Tumor Society (MSTS) and ORS) Organizers:
More informationPain management: making the most of the latest options
Vet Times The website for the veterinary profession https://www.vettimes.co.uk Pain management: making the most of the latest options Author : James Westgate Categories : Business, Business planning Date
More informationSUMMARY OF PRODUCT CHARACTERISTICS. Lincomycin (as Lincomycin hydrochloride) Neomycin (as Neomycin sulphate) Excipients Disodium edetate
SUMMARY OF PRODUCT CHARACTERISTICS AN: 00221/2013 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Lincocin Forte S Intramammary Solution 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Active substances Lincomycin
More informationComparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys. Géza Sárközy
Comparative studies on pulse and continuous oral norfloxacin treatment in broilers and turkeys Géza Sárközy Department of Pharmacology and Toxicology Faculty of Veterinary Science Szent István University
More information11/22/2016. Antimicrobial Stewardship Update Disclosures. Outline. No conflicts of interest to disclose
Antimicrobial Stewardship Update 2016 APIC-CI Conference November 17 th, 2016 Jay R. McDonald, MD Chief, ID Section VA St. Louis Health Care System Assistant Professor of medicine Washington University
More informationStreptomycin Sulfate According to USP
Application Note Antibiotics The most reliable LC-EC applications for Antibiotics analysis Aminoglycosides Amikacin Framycetin Sulphate Gentamicin Sulphate Kanamycin Sulphate Lincomycin Neomycin Spectinomycin
More informationAntibiotic Stewardship in the LTC Setting
Antibiotic Stewardship in the LTC Setting Joe Litsey, Director of Consulting Services Pharm.D., Board Certified Geriatric Pharmacist Thrifty White Pharmacy Objectives Describe the Antibiotic Stewardship
More informationCLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES THE AMINOGLYCOSIDES:
CLINICAL USE OF AMINOGLYCOSIDES AND FLUOROQUINOLONES Douglas Black, Pharm.D. Associate Professor School of Pharmacy University of Washington dblack@u.washington.edu THE AMINOGLYCOSIDES: 1944-1975 Drug
More informationFinnzymes Oy. PathoProof Mastitis PCR Assay. Real time PCR based mastitis testing in milk monitoring programs
PathoProof TM Mastitis PCR Assay Mikko Koskinen, Ph.D. Director, Diagnostics, Finnzymes Oy Real time PCR based mastitis testing in milk monitoring programs PathoProof Mastitis PCR Assay Comparison of the
More informationPharmacoeconomic Analysis of Peri-Surgical Antibiotics and Surgical Site Infections in Livingstone General Hospital, Zambia.
Pharmacoeconomic Analysis of Peri-Surgical Antibiotics and Surgical Site Infections in Livingstone General Hospital, Zambia. Martin Arrigan, Brigid Halley, Peter Hughes, Leanne McMenamin, Katie O Sullivan
More informationMeasure Information Form
Release Notes: Measure Information Form Version 2.0 **NQF-ENDORSED VOUNTRY CONSENSUS STNDRDS FOR HOSPIT CRE** Measure Information Form Measure Set: Surgical Care Improvement Project (SCIP) Set Measure
More informationBreast Reconstruction in the U.S.
The State of Antibiotic Use in Implant Based Breast Reconstruction Robert D. Foster, MD Professor of Surgery Division of Plastic and Reconstructive Surgery UCSF Breast Reconstruction in the U.S. Each year
More informationActive Bacterial Core Surveillance Site and Epidemiologic Classification, United States, 2005a. Copyright restrictions may apply.
Impact of routine surgical ward and intensive care unit admission surveillance cultures on hospital-wide nosocomial methicillin-resistant Staphylococcus aureus infections in a university hospital: an interrupted
More informationIntroduction to Chemotherapeutic Agents. Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018
Introduction to Chemotherapeutic Agents Munir Gharaibeh MD, PhD, MHPE School of Medicine, The university of Jordan November 2018 Antimicrobial Agents Substances that kill bacteria without harming the host.
More informationF1 IN THE NAME OF GOD
F1 IN THE NAME OF GOD Slide 1 F1 FEIKO.IR.SOFT; 2011/07/06 Lid Laceration Conjunctival Hemorrhage a) No therapy is necessary b) Usually resolve in 7-12 days. Subconjunctival Hemorrhage Corneal Abrasion
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More information